Long-term survival after multimodality treatment for resectable pancreatic cancer

被引:0
作者
Hideo Ozaki
Taira Kinoshita
Tomoo Kosuge
Kazuaki Shimada
Junji Yamamoto
Koichi Tokuuye
Noriyoshi Fukushima
Kiyoshi Mukai
机构
[1] National Cancer Center Hospital,Department of Radiotherapy
[2] National Cancer Center Hospital,Clinical Laboratory Division
[3] National Cancer Center Research Institute,Pathology Division
[4] National Cancer Center Hospital,Department of Surgery
来源
International Journal of Pancreatology | 2000年 / 27卷
关键词
Pancreatic cancer; multimodality treatment; pancreatectomy; intraoperative radiotherapy; chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
Background. The prognosis of pancreatic adenocarcinoma after radical pancreatectomy is poor, especially in advanced-stage disease.
引用
收藏
页码:217 / 224
页数:7
相关论文
共 143 条
[1]  
Ozaki H(1988)Multidisciplinary treatment for resectable pancreatic cancer Int J Pancreatol 3 249-259
[2]  
Hojo K(1990)Effectiveness of multimodality treatment for resectable pancreatic cancer Int J Pancreatol 7 195-200
[3]  
Kato H(1953)Catheter replacement of the needle in percutaneous arteriography: a new technique Acta Radiol 39 368-376
[4]  
Kinoshita T(1996)An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas Cancer 77 2240-2245
[5]  
Egawa S(1982)Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649-655
[6]  
Kishi K(1958)Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457-481
[7]  
Ozaki H(1985)Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 899-903
[8]  
Kinoshita T(1987)Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 2006-2010
[9]  
Kosuge T(1997)Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann Surg 225 621-636
[10]  
Egawa S(1999)Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Ann Surg 230 776-784